Evidence map›Paper›PMID 25609722›Full record

ArticleJournal of clinical microbiology2015

Evaluation of a low-density hydrogel microarray technique for mycobacterial species identification.

Danila V Zimenkov, Elena V Kulagina, Olga V Antonova, Maria A Krasnova, Ekaterina N Chernyaeva, Vyacheslav Y Zhuravlev, Alexey V Kuz'min, Sergey A Popov, Alexander S Zasedatelev, Dmitry A Gryadunov

Abstract read
In one paragraph

Article in Journal of clinical microbiology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Comparative Analysis of Evolutionary Distances Using the GenusInternational journal of molecular sciences · 2025
    Article
  2. Series 1: The Use ofTropical medicine and infectious disease · 2025
    Article
  3. Article
  4. Biochip-Based Identification of Mycobacterial Species in Russia.International journal of molecular sciences · 2024
    Article
  5. Article
  6. Characterization of three rapidly growing novelFrontiers in microbiology · 2023
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Danila V ZimenkovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation z@biochip.ru.
Elena V KulaginaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
Olga V AntonovaEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
Maria A KrasnovaMoscow Scientific and Clinical Antituberculosis Center, Department of Health of Moscow, Moscow, Russian Federation.
Ekaterina N ChernyaevaResearch Institute of Phthisiopulmonology, St. Petersburg, Russian Federation St. Petersburg State University, St. Petersburg, Russian Federation.
Vyacheslav Y ZhuravlevResearch Institute of Phthisiopulmonology, St. Petersburg, Russian Federation.
Alexey V Kuz'minResearch Institute of Phthisiopulmonology, I. M. Sechenov First Moscow State Medical Academy, Moscow, Russian Federation.
Sergey A PopovResearch Institute of Phthisiopulmonology, I. M. Sechenov First Moscow State Medical Academy, Moscow, Russian Federation.
Alexander S ZasedatelevEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.
Dmitry A GryadunovEngelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russian Federation.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In addition to the obligatory pathogenic species of the Mycobacterium tuberculosis complex and Mycobacterium leprae, the genus Mycobacterium also includes conditionally pathogenic species that in rare cases can lead to the development of nontuberculous mycobacterial diseases. Because tuberculosis and mycobacteriosis have similar clinical signs, the accurate identification of the causative agent in a clinical microbiology laboratory is important for diagnostic verification and appropriate treatment. This report describes a low-density hydrogel-based microarray containing oligonucleotide probes based on the species-specific sequences of the gyrB gene fragment for mycobacterial species identification. The procedure included the amplification of a 352-nucleotide fragment of the gene and its hybridization on a microarray. The triple-species-specific probe design and the algorithm for hybridization profile recognition based on the calculation of Pearson correlation coefficients, followed by the construction of a profile database, allowed for the reliable and accurate identification of mycobacterial species, including mixed-DNA samples. The assay was used to evaluate 543 clinical isolates from two regions of Russia, demonstrating its ability to detect 35 mycobacterial species, with 99.8% sensitivity and 100% specificity when using gyrB, 16S, and internal transcribed spacer (ITS) fragment sequencing as the standard. The testing of clinical samples showed that the sensitivity of the assay was 89% to 95% for smear-positive samples and 36% for smear-negative samples. The large number of identified species, the high level of sensitivity, the ability to detect mycobacteria in clinical samples, and the up-to-date profile database make the assay suitable for use in routine laboratory practice.

Indexed as

HumansHydrogel, Polyethylene Glycol DimethacrylateMolecular TypingMycobacteriumMycobacterium InfectionsNucleic Acid HybridizationOligonucleotide Array Sequence AnalysisPolymerase Chain ReactionHydrogel, Polyethylene Glycol Dimethacrylate

Identifiers

PMID25609722
PMCPMC4365248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.